Shares Held (Direct Ownership) 23.3K
55.13% 3M change
n/a 12M change
Total Value Held N/A

Louise Frederika Kooij Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2025
BUY
Exercise of conversion of derivative security
-
8,269 Added 26.22%
23,269 Ordinary Shares
Mar 04 2025
SELL
Open market or private sale
$3,055,500 $20.37 p/Share
150,000 Reduced 90.91%
15,000 Ordinary Shares
Mar 04 2025
BUY
Exercise of conversion of derivative security
-
150,000 Added 47.62%
165,000 Ordinary Shares
Jan 07 2025
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Ordinary Shares
Oct 01 2024
SELL
Open market or private sale
$707,400 $15.72 p/Share
45,000 Reduced 100.0%
0 Ordinary Shares
Sep 27 2024
BUY
Exercise of conversion of derivative security
-
45,000 Added 50.0%
45,000 Ordinary Shares
LFK

Louise Frederika Kooij

Chief Accounting Officer
Naarden, P7

Track Institutional and Insider Activities on NAMS

Follow NewAmsterdam Pharma Co N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAMS shares.

Notify only if

Insider Trading

Get notified when an New Amsterdam Pharma CO N.V. insider buys or sells NAMS shares.

Notify only if

News

Receive news related to NewAmsterdam Pharma Co N.V.

Track Activities on NAMS